Hamburg, Senior Panel Continue “Rethinking” FDA Organization
This article was originally published in The Tan Sheet
Commissioner Margaret Hamburg awaits recommendations from a panel of senior agency officials on how to ensure FDA’s centers support Office of Regulatory Affairs’ activities without duplication.
You may also be interested in...
FDA Commissioner Hamburg has appointed 10 officials to come up with a plan to realign the agency, with the goal of moving toward a “specialized program-based model.”